نتایج جستجو برای: gynecologic tumors

تعداد نتایج: 183856  

Introduction: Involving approximately 4% of malignancies in women, ovarian cancer remains one of the most fatal cancers. However, it is important to consider conditions which are not primary ovarian diseases, but mimic their behaviors. In the present study, the epidemiological characteristics of extra-ovarian conditions mimicking ovarian masses are evaluated. Meth...

Journal: :Ginekologia polska 2016
Sebastian Szubert Artur Łojewski Rafał Moszyński Arkadiusz Lisowski Stefan Sajdak Dariusz Szpurek

OBJECTIVES Subjective ultrasonographic assessment is currently considered to be the best method of differentiation between various types of ovarian tumors. The aim of the study was to evaluate selected ultrasonographic features and CA125 levels of hormonally active ovarian tumors. MATERIAL AND METHODS A total of 1135 women with ovarian tumors were diagnosed between 2006 and 2014 at the Divisi...

Journal: :Libri oncologici 2022

The aim of this review article is to present current options for fertility preservation in young women with gynecological tumors (ovarian, endometrial or cervical cancer). An early pretreatment referral multidisciplinary team which consists general gynecologists, gynecologic oncologists, embryologists, radiologists, pathologists, and reproductive endocrinologists should be suggested cancer, con...

2014
Tao Ji Ramez Eskander Yifei Wang Kunkun Sun Bang H Hoang Wei Guo

BACKGROUND The evaluation, counseling, and management of gynecologic patients with bone metastasis remain a challenge for clinicians. In order to critically evaluate the role of surgery, we retrospectively analyzed the records of 18 patients surgically treated for metastatic gynecologic tumors of bone, focusing on quality of life, local tumor control, and survival. METHODS Eighteen patients u...

2014
Sarina A. Piha-Paul Jennifer J. Wheler Siqing Fu Charles Levenback Karen Lu Gerald S. Falchook Aung Naing David S. Hong Apostolia M. Tsimberidou Razelle Kurzrock

BACKGROUND Bevacizumab and temsirolimus are active agents in gynecologic tumors. Temsirolimus attenuates upregulation of HIF-1α levels, a resistance mechanism for antiangiogenics, and targets the PI3-kinase/AKT/mTOR axis, commonly aberrant in these tumors. PATIENTS AND METHODS We analyzed safety and responses in 41 patients with gynecologic cancers treated as part of a Phase I study of bevaci...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید